Literature DB >> 18642893

Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.

Tero Huhtiniemi1, Tiina Suuronen, Valtteri M Rinne, Carsten Wittekindt, Maija Lahtela-Kakkonen, Elina Jarho, Erik A A Wallén, Antero Salminen, Antti Poso, Jukka Leppänen.   

Abstract

A new inhibitor for human sirtuin type proteins 1 and 2 (SIRT1 and SIRT2) was discovered through virtual database screening in search of new scaffolds. A series of compounds was synthesized based on the hit compound (3-[[3-(4-tert-butylphenyl)1,2,4-oxadiazole-5-carbonyl]amino]-1-[3-(trifluoromethyl)phenyl]thiourea). The most potent compound in the series was nearly as potent as the reference compound (6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642893     DOI: 10.1021/jm800639h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.

Authors:  Jie Xia; Ermias Lemma Tilahun; Eyob Hailu Kebede; Terry-Elinor Reid; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2015-02-09       Impact factor: 4.956

2.  Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.

Authors:  Mohammad A Khanfar; Luisa Quinti; Hua Wang; Soo Hyuk Choi; Aleksey G Kazantsev; Richard B Silverman
Journal:  Eur J Med Chem       Date:  2014-02-06       Impact factor: 6.514

3.  Design of a novel nucleoside analog as potent inhibitor of the NAD dependent deacetylase, SIRT2.

Authors:  Padavattan Sivaraman; Suresh Mattegunta; Gottumukkala V Subbaraju; Chava Satyanarayana; Balasundaram Padmanabhan
Journal:  Syst Synth Biol       Date:  2011-02-23

4.  Identification and characterization of novel sirtuin inhibitor scaffolds.

Authors:  Brandi D Sanders; Brittany Jackson; Michael Brent; Alexander M Taylor; Weiwei Dang; Shelley L Berger; Stuart L Schreiber; Konrad Howitz; Ronen Marmorstein
Journal:  Bioorg Med Chem       Date:  2009-08-03       Impact factor: 3.641

Review 5.  Mechanisms and molecular probes of sirtuins.

Authors:  Brian C Smith; William C Hallows; John M Denu
Journal:  Chem Biol       Date:  2008-10-20

6.  Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.

Authors:  Federico Medda; Rupert J M Russell; Maureen Higgins; Anna R McCarthy; Johanna Campbell; Alexandra M Z Slawin; David P Lane; Sonia Lain; Nicholas J Westwood
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

7.  Characterization of the anticancer effects of S115, a novel heteroaromatic thiosemicarbazone compound, in vitro and in vivo.

Authors:  Min-yu Liu; Lin Xiao; Yu-qiong Dong; Ying Liu; Li Cai; Wei-xia Xiong; Yu-long Yao; Ming Yin; Quan-hai Liu
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

Review 8.  Rejuvenating sirtuins: the rise of a new family of cancer drug targets.

Authors:  Santina Bruzzone; Marco Daniele Parenti; Alessia Grozio; Alberto Ballestrero; Inga Bauer; Alberto Del Rio; Alessio Nencioni
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.

Authors:  Maria Fridén-Saxin; Tina Seifert; Marie Rydén Landergren; Tiina Suuronen; Maija Lahtela-Kakkonen; Elina M Jarho; Kristina Luthman
Journal:  J Med Chem       Date:  2012-08-07       Impact factor: 7.446

10.  BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses.

Authors:  Tarja Kokkola; Tiina Suuronen; Maija Pesonen; Panagis Filippakopoulos; Antero Salminen; Elina M Jarho; Maija Lahtela-Kakkonen
Journal:  Chembiochem       Date:  2015-08-13       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.